Kosterlitz H W, Lord J A, Paterson S J, Waterfield A A
Br J Pharmacol. 1980 Feb;68(2):333-42. doi: 10.1111/j.1476-5381.1980.tb10422.x.
1 The activity pattern of analogues of the enkephalins was determined in four parallel assays, the inhibition of the electrically evoked contraction of the guinea-pig ileum and mouse vas deferens at 36 degrees C and the inhibition of [(3)H]-naltrexone and [(3)H]-leucine-enkephalin binding at 0 to 4 degrees C in homogenates of guinea-pig brain.2 The activity pattern was best characterized by the ratio of the potency in the guinea-pig ileum to that in the mouse vas deferens (G.p.i./M.v.d.) and the ratio of the potency in inhibiting [(3)H]-naltrexone binding to that in inhibiting [(3)H]-leucine-enkephalin binding (Nal/Leu).3 The enkephalins had low G.p.i./M.v.d. (0.02 to 0.09) and low Nal/Leu (0.05 to 0.18) ratios whereas the corresponding values for morphine were 7.0 and 7.5.4 Analogues obtained by substituting D-Ala for Gly(2) and D-Met or D-Leu for L-Met(5) or L-Leu(5) showed only minor changes in G.p.i./M.v.d. (0.01 to 0.11) and in Nal/Leu (0.06 to 0.13) ratios.5 Analogues in which resistance to enzymatic degradation was brought about by amidation of the C-terminal carboxylic group or methylation of the amino group of tyrosine or both modifications, had G.p.i./M.v.d. ratios of 1.2 to 5.5 and Nal/Leu ratios of 0.5 to 21. High values (2.1 and 3.4) were found for the potent antinociceptive analogue of Sandoz, Tyr-D-Ala-Gly-NCH(3)Phe-Met(O)-ol.6 In the mouse vas deferens, some of the analogues with high G.p.i./M.v.d. and Nal/Leu ratios were tested for antagonism by naloxone and found to require less than the high concentration needed for the natural enkephalins. C57/BL mice, which have a lowered sensitivity to morphine but a normal response to peptides with low G.p.i./M.v.d. and Nal/Leu ratios, had a lowered sensitivity to analogues with high ratios.7 In the alkaloid-like series of narcotic analgesic drugs, ketobemidone, levorphanol, methadone, etorphine and the antagonist Mr 2266 had lower Nal/Leu ratios (1.0 to 2.8) than morphine, normorphine, naloxone and naltrexone (8 to 12).8 It would appear that compounds with low G.p.i./M.v.d. and Nal/Leu ratios interact mainly with delta-receptors in the brain and peripheral nervous system while compounds with high ratios interact mainly with mu-receptors. For antinociceptive action mu-receptors may be more important than delta-receptors.
在四项平行试验中测定了脑啡肽类似物的活性模式,包括在36℃时对豚鼠回肠和小鼠输精管电诱发收缩的抑制作用,以及在0至4℃时对豚鼠脑匀浆中[³H] - 纳曲酮和[³H] - 亮氨酸 - 脑啡肽结合的抑制作用。
活性模式的最佳特征是豚鼠回肠中的效力与小鼠输精管中的效力之比(G.p.i./M.v.d.)以及抑制[³H] - 纳曲酮结合的效力与抑制[³H] - 亮氨酸 - 脑啡肽结合的效力之比(Nal/Leu)。
脑啡肽的G.p.i./M.v.d.比值较低(0.02至0.09)且Nal/Leu比值较低(0.05至0.18),而吗啡的相应值分别为7.0和7.5。
用D - Ala替代Gly(2)以及用D - Met或D - Leu替代L - Met(5)或L - Leu(5)得到的类似物,其G.p.i./M.v.d.比值(0.01至0.11)和Nal/Leu比值(0.06至0.13)仅显示出微小变化。
通过C末端羧基酰胺化、酪氨酸氨基甲基化或两者修饰而产生对酶促降解抗性的类似物,其G.p.i./M.v.d.比值为1.2至5.5,Nal/Leu比值为0.5至21。山德士公司的强效抗伤害感受类似物Tyr - D - Ala - Gly - NCH(3)Phe - Met(O) - ol具有较高的值(2.1和3.4)。
在小鼠输精管中,对一些具有高G.p.i./M.v.d.和Nal/Leu比值的类似物进行了纳洛酮拮抗试验,发现它们所需的浓度低于天然脑啡肽所需的高浓度。C57/BL小鼠对吗啡的敏感性降低,但对具有低G.p.i./M.v.d.和Nal/Leu比值的肽有正常反应,对具有高比值的类似物敏感性降低。